Clinical trials
Epilepsy, Generalized trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2024 | 2 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Recruiting | 3 |
| Terminated | 2 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 3 |
| UCB Pharma | 3 |
| Lundbeck LLC | 2 |
| All India Institute of Medical Sciences, Bhubaneswar | 1 |
| Arak University of Medical Sciences | 1 |
| Bio-Signal Group Corp. | 1 |
| Biohaven Therapeutics Ltd. | 1 |
| Central Hospital, Nancy, France | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| Chinese University of Hong Kong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsy, Generalized | 37 |
| Epilepsy | 18 |
| Seizures | 16 |
| Epilepsies, Partial | 10 |
| Drug Resistant Epilepsy | 3 |
| Epilepsy, Absence | 3 |
| Lennox Gastaut Syndrome | 3 |
| Autistic Disorder | 1 |
| Communicable Diseases | 1 |
| Communication Disorders | 1 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.